Pharmaceuticals News

Company Announcement no. 12/2014    To: NASDAQ OMX Copenhagen A/S                  ...

Selskabsmeddelelse nr. 12/2014    Til: NASDAQ OMX Copenhagen A/S                  ...

Company Announcement no. 11/2014   To: NASDAQ OMX Copenhagen A/S Hørsholm, Denmark, 14 May, 2014    Veloxis Pharmaceuticals announces financial results for the first three...

Selskabsmeddelelse København, Danmark, 14. maj 2014 – I henhold til værdipapirhandelslovens § 28a, indberetter Genmab A/S (OMX: GEN) hermed på vegne af ledende medarbejdere oplysninger om ledende...

Company Announcement Copenhagen, Denmark; May 14, 2014 — Pursuant to Section 28a of the Danish Securities Trading Act, Genmab A/S (OMX: GEN) hereby, on behalf of managerial employees, makes public...

Selskabsmeddelelse København, Danmark, 14. maj 2014 – Genmab A/S (OMX: GEN) forhøjer selskabets aktiekapital med 58.064 aktier som følge af udnyttelse af medarbejderwarrants. Kapitalforhøjelsen...

Company Announcement Copenhagen, Denmark; May 14, 2014 – Genmab A/S (OMX: GEN) will increase its share capital by 58,064 shares as a consequence of the exercise of employee warrants. The...

LITTLE RIVER, S.C., May 14, 2014 (GLOBE NEWSWIRE) -- Integrated Environmental Technologies, Ltd. (OTCBB:IEVM) today announced its management team will host a conference call on Tuesday, May 20, 2014,...

PHILADELPHIA, May 14, 2014 (GLOBE NEWSWIRE) -- Hemispherx Biopharma, Inc. (NYSE MKT:HEB) (the "Company" or "Hemispherx"), announced that it has entered into a formal collaborative research agreement...

BURLINGTON, Mass., May 14, 2014 (GLOBE NEWSWIRE) -- Coronado Biosciences, Inc. (Nasdaq:CNDO) today announced that it has initiated a Phase 2a clinical trial of TSO (Trichuris suis ova or CNDO-201) for...